Pancreatic Cancer Research

ResearcherCentral South UniversityActive in the last 2 years

Qing Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4661-3681; OpenAlex author ID A5100404184. Sources: OpenAlex.

Their work

Papers
7
Trials
0
Grants
0
Labs led
0
Collaborators
20
Papers, trials and grants by year

2016: 3 papers · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper

Papers 7

  1. REG3A promotes gemcitabine resistance in pancreatic cancer via the GPR54/ARRB2/ERK1/2 ligand-directed signaling pathway. Co-author DOI 10.1016/j.bcp.2025.117322↗
  2. Development and Validation of an Inflammatory Response-Related Gene Signature for Predicting the Prognosis of Pancreatic Adenocarcinoma. Co-author DOI 10.1007/s10753-022-01657-6↗
  3. Analysis of the Curative Effect of Neoadjuvant Therapy on Pancreatic Cancer. Co-author DOI 10.3389/fonc.2021.695645↗
  4. P-glycoprotein associated with diabetes mellitus and survival of patients with pancreatic cancer: 8-year follow-up. Co-author DOI 10.1590/1414-431x202010168↗
  5. Beyond the dollar: Influence of sociodemographic marginalization on surgical resection, adjuvant therapy, and survival in patients with pancreatic cancer. Co-author DOI 10.1002/cncr.30148↗
  6. The association of adjuvant therapy with survival at the population level following pancreatic adenocarcinoma resection. Co-author DOI 10.1016/j.hpb.2015.12.005↗
  7. Reg proteins promote acinar-to-ductal metaplasia and act as novel diagnostic and prognostic markers in pancreatic ductal adenocarcinoma. Co-author DOI 10.18632/oncotarget.12834↗

Closest collaborators

The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jia Liu · 1 shared paper, 2025 · strength 0.24
  2. Senlin Li · 1 shared paper, 2025 · strength 0.24
  3. Cheng Tian · 1 shared paper, 2025 · strength 0.24
  4. Ming Xiang · 1 shared paper, 2025 · strength 0.24
  5. Zuliang Deng · 1 shared paper, 2022 · strength 0.19
  6. Hui Xie · 1 shared paper, 2022 · strength 0.19
  7. Xiechuan Weng · 1 shared paper, 2021 · strength 0.15
  8. Jie Chen · 1 shared paper, 2021 · strength 0.15
  9. Liqiong Yang · 1 shared paper, 2021 · strength 0.15
  10. Fan Xu · 1 shared paper, 2021 · strength 0.15
  11. Nan Hu · 1 shared paper, 2020 · strength 0.11
  12. Rong Chen · 1 shared paper, 2020 · strength 0.11
  13. Daniel Jonathan Kagedan · 2 shared papers, 2016 · strength 0.11
  14. Natalie G. Coburn · 2 shared papers, 2016 · strength 0.11
  15. Zu‐Hua Gao · 1 shared paper, 2016 · strength 0.05
  16. Hao Wang · 1 shared paper, 2016 · strength 0.05
  17. George Zogopoulos · 1 shared paper, 2016 · strength 0.05
  18. Nicole Mittmann · 1 shared paper, 2016 · strength 0.05
  19. R.S. Raju · 1 shared paper, 2016 · strength 0.05
  20. Matthew E. B. Dixon · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.